If you're in the bull camp on TUES, then I would look for long-biased as long once this stock manages to break out above some near-term overhead resistance levels at $6.21 to $6.49 a share, and then above more resistance at $6.86 a share with high volume. Look for volume on that move that registers near or above is three-month average action of 224,630 shares. If that breakout triggers soon, then look for TUES to trend well north of $7 a share and possibly towards $9 a share.
The last name to consider with some decent insider buying is biotechnology and drugs player NovaBay Pharmaceuticals (NBY - Get Report). This company is engaged in the discovery and development of innovative product candidates for the treatment or prevention of a range of infections in hospital and non-hospital environments. This stock has traded flat so far in 2012, with shares down by just 1.5%.
NovaBay Pharmaceuticals has a market cap of $38.79 and an enterprise value of $27.68 million. Its estimated growth rate for this year is -45%, and for next year it's pegged at 10.3%. This is a cash-rich company, since the total cash position on its balance sheet is $11.88 million and its total debt is zero.A beneficial owner just bought 398,800 shares, or around $3.17 million worth of stock, at $7.83 to $8.02 per share. From a technical perspective, NBY is currently trending just above its 50-day and 200-day moving averages, which is bullish. This stock has been trending sideways for the past month and change, with shares moving between $1.11 on the downside and $1.40 on the upside. A high-volume move outside of that range will likely setup the next major trend for shares of NBY. If you're bullish on NBY, then I would look for long-biased once this stock manages to break out above some near-term overhead resistance at $1.40 a share with high volume. Look for a sustained move or close above $1.40 a share with volume that hits near or above its three-month average action of 146,510 shares. If NBY triggers that move soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $1.56 to $1.58 a share. Any high-volume move above those levels will then set up NBY to take out more resistance levels at $1.72 to $2.20 a share.